Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Injection site reactions
ADR ID BADD_A02349
ADR Hierarchy
08      General disorders and administration site conditions
08.02      Administration site reactions
08.02.03      Injection site reactions
12      Injury, poisoning and procedural complications
12.07      Administration site reactions
12.07.03      Injection site reactions
Description Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA. [MeSH]
MedDRA Code 10022097
MeSH ID D000075662
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Injection Site Reaction | Injection Site Reactions | Injection Site Event | Injection Site Events | Injection Site Adverse Event | Infusion Site Reaction | Infusion Site Reactions | Infusion Site Adverse Reaction | Infusion Site Adverse Event
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02105Tacrolimus0.000297%
BADD_D02111Tamoxifen--
BADD_D02123Technetium--
BADD_D02127Technetium tc-99m fanolesomab--
BADD_D02132Technetium tc-99m sestamibi--
BADD_D02134Technetium tc-99m tilmanocept--
BADD_D02137Teduglutide--
BADD_D02138Teduglutide recombinant--
BADD_D02147Telmisartan--
BADD_D02149Temoporfin--
BADD_D02162Terbutaline--
BADD_D02166Teriparatide--
BADD_D02167Terlipressin--
BADD_D02168Tesamorelin--
BADD_D02170Testosterone--
BADD_D02171Testosterone cypionate0.115537%
BADD_D02172Testosterone enanthate-
BADD_D02174Testosterone undecanoate-
BADD_D02179Tetracycline--
BADD_D02187Tetrakis(1-isocyano-2-methoxy-2-methyl-propane)-copper(i) tetrafluoroborate--
BADD_D02188Tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate--
BADD_D02203Thiotepa--
BADD_D02214Ticagrelor0.000925%
BADD_D02217Tigecycline--
BADD_D02222Tinzaparin sodium--
BADD_D02230Tizanidine0.000141%
BADD_D02232Tobramycin--
BADD_D02233Tobramycin sulfate--
BADD_D02247Topiramate0.000759%
BADD_D02252Tositumomab--
The 20th Page    First    Pre   20 21 22 23    Next   Last    Total 23 Pages
ADReCS-Target
ADR Term Drug Name Target